This announcement is a separate document:
免疫生物研究所：抗重症熱性血小板減少症候群（SFTS）ウイルス抗体遺伝子の独占的実施許諾契約締結に関するお知らせ
Immuno-Biological Laboratories: Announcements of individual stocks: Exclusive licensing agreement signed for the SFTS virus antibody gene against severe fever with thrombocytopenia syndrome.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.